Concepedia

M. Alper Kursunel

MA

Statistics

Publications

6

Citations

230

H-Index

6

Active since

2015

Affiliations

Hacettepe University(Current)

University Hospital Carl Gustav Carus

University Medical Center Hamburg-Eppendorf

National Center for Tumor Diseases

Universität Hamburg

M. Alper Kursunel is an author at Hacettepe University specializing in oncology, cytotoxic t lymphocyte responses, and cd8 positive t cells.

ORCID

Publications per year

2015–2025

6

Publications

6

Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression

Alberto Sada Japp, M. Alper Kursunel, Sarah Meier et al. · Cancer Immunology Immunotherapy · 2015 · 64 citations · Full text

, , +16

Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial

Martin Wermke, Dejka M Araurjo, Manik Chatterjee et al. · Nature Medicine · 2025 · 46 citations · Full text

, , +17

Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes

M. Alper Kursunel, Ekim Z. Taşkıran, Ece Tavukçuoğlu et al. · Cancer Immunology Immunotherapy · 2021 · 41 citations · Full text

, , +17

Design and in vitro evaluation of folate-targeted, co-drug encapsulated theranostic liposomes for non-small cell lung cancer

Merve Karpuz, Mine Silindir‐Gunay, M. Alper Kursunel et al. · Journal of Drug Delivery Science and Technology · 2020 · 29 citations

, , +16

First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors

Martin Wermke, Tobias A.W. Holderried, Jason J. Luke et al. · Journal for ImmunoTherapy of Cancer · 2024 · 27 citations · Full text

, , +17

1–5 of 6